Testing effectiveness (Phase 2)Study completedNCT00859534What this trial is testingPhase II Solar Urticaria (SU) Pilot StudyWho this might be right forSolar Urticaria Clinuvel Pharmaceuticals Limited 5
Testing effectiveness (Phase 2)Study completedNCT01360658What this trial is testingIntravenous Immunoglobulins in Severe and Refractory Solar UrticariaWho this might be right forSolar Urticaria Centre Hospitalier Universitaire de Besancon 10
Large-scale testing (Phase 3)Study completedNCT00991146What this trial is testingEfficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension PhaseWho this might be right forCryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more Novartis Pharmaceuticals 19
Testing effectiveness (Phase 2)Study completedNCT00094900What this trial is testingInterleukin-1 Trap to Treat Autoinflammatory DiseasesWho this might be right forInflammationFamilial Mediterranean FeverStill's Disease, Adult-Onset National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 11
Early research (Phase 1)Study completedNCT06050928What this trial is testingPhase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible UrticariaWho this might be right forChronic Inducible Urticaria Escient Pharmaceuticals, Inc 33
Testing effectiveness (Phase 2)Ended earlyNCT02853084What this trial is testingHL2351 CAPS Phase II StudyWho this might be right forCryopyrin-Associated Periodic Syndromes (CAPS) Handok Inc. 8
Early research (Phase 1)Study completedNCT04086602What this trial is testingSafety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334Who this might be right forHealthy VolunteersCryopyrin Associated Periodic Syndrome Inflazome UK Ltd 64
Large-scale testing (Phase 3)Active Not RecruitingNCT05976243What this trial is testingInvestigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistaminesWho this might be right forChronic Inducible Urticaria Novartis Pharmaceuticals 362
Testing effectiveness (Phase 2)Study completedNCT02262130What this trial is testingOmalizumab in Severe and Refractory Solar UrticariaWho this might be right forSolar Urticaria Centre Hospitalier Universitaire de Besancon 10
Not applicableEnded earlyNCT03219918What this trial is testingAdenoma Detection Rate in Colonoscopy Performed With EndoRingsWho this might be right forColorectal AdenomaColorectal Neoplasms Zealand University Hospital 97
Testing effectiveness (Phase 2)Study completedNCT05186051What this trial is testingA Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS)Who this might be right forCryopyrin Associated Periodic Syndrome Zydus Lifesciences Limited 3
Not applicableStudy completedNCT07450170What this trial is testingA Real-World Study of Omalizumab Treatment Patterns in Chronic Urticaria Patients in ChinaWho this might be right forChronic Urticaria Novartis Pharmaceuticals 3,485
Large-scale testing (Phase 3)Study completedNCT00465985What this trial is testingEfficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells SyndromeWho this might be right forMuckle Wells Syndrome Novartis 35
Early research (Phase 1)Looking for participantsNCT07247266What this trial is testingStudy to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS)Who this might be right forCryopyrin-associated Periodic Syndromes (CAPS) Akros Pharma Inc. 5
Early research (Phase 1)Looking for participantsNCT07181369What this trial is testingGTX-B001 in Healthy Subjects and Patients With Chronic Inducible UrticariaWho this might be right forHealthy SubjectsCold UrticariaSymptomatic Dermographism+1 more Granular Therapeutics Limited 72
Not applicableLooking for participantsNCT02974595What this trial is testingNatural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)Who this might be right forNOMIDDIRANLRC4-MAS+2 more National Institute of Allergy and Infectious Diseases (NIAID) 3,200
Post-approval studies (Phase 4)Study completedNCT01586091What this trial is testingSafety Study of Levocetirizine and FexofenadineWho this might be right forPruritusChronic UrticariaAllergic Rhinitis Charite University, Berlin, Germany 18
Large-scale testing (Phase 3)Ended earlyNCT00770601What this trial is testingCanakinumab to Treat Neonatal-Onset Multisystem Inflammatory DiseaseWho this might be right forNOMIDCINCA Syndrome Novartis Pharmaceuticals 7
Not applicableLooking for participantsNCT07833696What this trial is testingCharacteristics and Management of Patients With Severe Chronic Spontaneous and/or Inducible Urticaria Refractory to Optimized Omalizumab Treatment: A French Multicenter Observational Study.Who this might be right forChronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU) Centre Hospitalier Universitaire de Besancon 73
Not applicableStudy completedNCT04856540What this trial is testingAdult Outcomes of Children With CAPSWho this might be right forCryopyrin Associated Periodic Syndrome University Hospital, Lille 54